Claritev (CTEV) Liabilities and Shareholders Equity (2019 - 2026)
Claritev (CTEV) recorded quarterly Liabilities and Shareholders Equity of $4.8 billion in Q1 2026, down 1.01% quarter-over-quarter from $4.9 billion in Q4 2025, and down 4.82% on a YoY basis from $5.1 billion in Q1 2025.
Claritev (CTEV) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends
Claritev's Liabilities and Shareholders Equity history runs 8 years deep, the most recent figure standing at $4.8 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 4.82% year-over-year to $4.8 billion; the TTM figure through Mar 2026 stood at $19.8 billion (down 7.08% YoY), while the FY2025 annual figure was $4.9 billion, down 5.09% from the prior year.
- Liabilities and Shareholders Equity was $4.8 billion for Q1 2026 at Claritev, down from $4.9 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $8.3 billion in Q1 2022 to a low of $4.8 billion in Q1 2026.
- Historically, Liabilities and Shareholders Equity has averaged $6.3 billion across 5 years, with a median of $6.4 billion in 2024.
- The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity decreased 0.95% in 2022, then retreated 26.04% in 2024.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $7.4 billion in 2022, then fell by 5.51% to $7.0 billion in 2023, then declined by 26.04% to $5.2 billion in 2024, then decreased by 5.09% to $4.9 billion in 2025, then declined by 1.01% to $4.8 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $4.8 billion (Q1 2026), $4.9 billion (Q4 2025), and $5.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn | 9.13 Bn |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn | 6.21 Bn |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn | 3.31 Bn |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn | 728.77 Mn |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn | 1.12 Bn |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn | 1.02 Bn |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn | 5.84 Bn |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn | 1.42 Bn |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn | 2.00 Bn |
| 10 | Claritev | 524.72 Mn | 496.72 Mn | 175.60 Mn | 4.84 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.84 Bn |
| Dec 31, 2025 | 4.89 Bn |
| Sep 30, 2025 | 4.99 Bn |
| Jun 30, 2025 | 5.07 Bn |
| Mar 31, 2025 | 5.08 Bn |
| Dec 31, 2024 | 5.15 Bn |
| Sep 30, 2024 | 5.32 Bn |
| Jun 30, 2024 | 5.74 Bn |
| Mar 31, 2024 | 6.37 Bn |
| Dec 31, 2023 | 6.96 Bn |
| Sep 30, 2023 | 7.06 Bn |
| Jun 30, 2023 | 7.14 Bn |
| Mar 31, 2023 | 7.22 Bn |
| Dec 31, 2022 | 7.37 Bn |
| Sep 30, 2022 | 8.19 Bn |
| Jun 30, 2022 | 8.22 Bn |
| Mar 31, 2022 | 8.28 Bn |
| Dec 31, 2021 | 8.22 Bn |
| Sep 30, 2021 | 8.28 Bn |
| Jun 30, 2021 | 8.34 Bn |